Vaccination against HPV-16 for vulvar intraepithelial neoplasia. 2010

Isabelle Bourgault Villada

UI MeSH Term Description Entries
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014846 Vulvar Neoplasms Tumors or cancer of the VULVA. Cancer of Vulva,Vulvar Cancer,Cancer of the Vulva,Neoplasms, Vulvar,Vulva Cancer,Vulva Neoplasms,Cancer, Vulva,Cancer, Vulvar,Cancers, Vulva,Cancers, Vulvar,Neoplasm, Vulva,Neoplasm, Vulvar,Neoplasms, Vulva,Vulva Cancers,Vulva Neoplasm,Vulvar Cancers,Vulvar Neoplasm
D052162 Human papillomavirus 16 A type of ALPHAPAPILLOMAVIRUS especially associated with malignant tumors of the CERVIX and the RESPIRATORY MUCOSA. HPV 16,HPV16,Human papillomavirus - 16,Human papillomavirus type 16,human papillomavirus type 16 HPV 16,human papillomavirus type 16 HPV16,HPV-16,HPV 16s,HPV16s
D053918 Papillomavirus Vaccines Vaccines or candidate vaccines used to prevent PAPILLOMAVIRUS INFECTIONS. Human vaccines are intended to reduce the incidence of UTERINE CERVICAL NEOPLASMS, so they are sometimes considered a type of CANCER VACCINES. They are often composed of CAPSID PROTEINS, especially L1 protein, from various types of ALPHAPAPILLOMAVIRUS. HPV Vaccine,Human Papilloma Virus Vaccine,Human Papillomavirus Vaccine,Human Papillomavirus Vaccines,Papillomavirus Vaccine,HPV Vaccines,Human Papilloma Virus Vaccines,Papillomavirus Vaccine, Human,Papillomavirus Vaccines, Human,Vaccine, HPV,Vaccine, Human Papillomavirus,Vaccine, Papillomavirus,Vaccines, Human Papillomavirus,Vaccines, Papillomavirus
D055815 Young Adult A person between 19 and 24 years of age. Adult, Young,Adults, Young,Young Adults
D030361 Papillomavirus Infections Neoplasms of the skin and mucous membranes caused by papillomaviruses. They are usually benign but some have a high risk for malignant progression. HPV Infection,Human Papillomavirus Infection,HPV Infections,Human Papillomavirus Infections,Papillomavirus Infection,Papillomavirus Infection, Human,Papillomavirus Infections, Human

Related Publications

Isabelle Bourgault Villada
November 2009, The New England journal of medicine,
Isabelle Bourgault Villada
February 2006, Gynecologic oncology,
Isabelle Bourgault Villada
May 1992, Lancet (London, England),
Isabelle Bourgault Villada
November 2019, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
Isabelle Bourgault Villada
June 2023, The Lancet. Oncology,
Isabelle Bourgault Villada
June 2023, The Lancet. Oncology,
Isabelle Bourgault Villada
January 2012, The New England journal of medicine,
Isabelle Bourgault Villada
May 2009, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
Isabelle Bourgault Villada
July 2009, The New England journal of medicine,
Copied contents to your clipboard!